Arcturus Therapeutics
ARCT
ARCT
143 hedge funds and large institutions have $336M invested in Arcturus Therapeutics in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 144 → 143 (-1)
3.13% less ownership
Funds ownership: 98.14% → 95.01% (-3.1%)
Holders
143
Holding in Top 10
–
Calls
$5.16M
Puts
$2.01M
Top Buyers
| 1 | +$4.57M | |
| 2 | +$3.05M | |
| 3 | +$1.61M | |
| 4 |
Goldman Sachs
New York
|
+$1.44M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.33M |
Top Sellers
| 1 | -$4.89M | |
| 2 | -$3.82M | |
| 3 | -$3.39M | |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$3.38M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$2.24M |
